Macrophage-derived IL-18 targeting for the treatment of Crohn's disease

Curr Drug Targets Inflamm Allergy. 2003 Jun;2(2):131-6. doi: 10.2174/1568010033484250.

Abstract

Crohn's disease is an inflammatory bowel disease associated with several changes in the immune system, including an increased number of infiltrating macrophages. These macrophages release a variety of proinflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha, macrophage infiltrating factor (MIF), interleukin (IL)-6, IL-12 and IL-18, which are critically involved in the onset and the development of Crohn's disease. We here focus on the role of macrophages, especially macrophage-derived IL-18 in both patients with Crohn's disease and a murine model of Crohn's disease.

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacology
  • Crohn Disease / drug therapy*
  • Crohn Disease / physiopathology
  • Disease Models, Animal
  • Drug Delivery Systems
  • Humans
  • Immunotoxins / pharmacology
  • Interleukin-18 / physiology*
  • Macrophages / physiology*
  • Membrane Glycoproteins / drug effects
  • Membrane Glycoproteins / physiology
  • Receptors, Cell Surface / drug effects
  • Receptors, Cell Surface / physiology
  • Toll-Like Receptors

Substances

  • Antibodies, Monoclonal
  • Immunotoxins
  • Interleukin-18
  • Membrane Glycoproteins
  • Receptors, Cell Surface
  • Toll-Like Receptors